Skip to content

    Oriental Aromat.

    OAL
    Chemicals·21 May 2026
    Management Summary

    Oriental Aromatics Limited reported a milestone FY26 with revenue crossing INR 1,000 crore, driven by healthy volume growth. However, profitability was significantly impacted by raw material inflation, currency depreciation, and the ramp-up costs of the Mahad plant, leading to compressed EBITDA and PAT margins for the full year. Management is focused on internal efficiencies and expects Mahad to become EBITDA neutral within the next year.

    Highlights

    5
    • FY26 revenue reached INR 1,030.8 crores, marking the first time crossing INR 1,000 crore, representing an 11% YoY growth.

    • Q4 FY26 operating revenue stood at INR 282 crore, reflecting a healthy growth of 12% QoQ and 11% YoY.

    • Q4 FY26 EBITDA margins improved to 6.89% from 5.26% in the previous quarter.

    • Q4 FY26 total sales volume increased by 16% QoQ and registered a 5% growth YoY.

    • Mahad plant has completed sampling cycles with global customers and commercial shipments have commenced.

    Concerns

    6
    • FY26 EBITDA margins compressed to 6.60% from 10.06% in FY25.

    • FY26 PAT margins stood at 0.32% compared to 3.7% in FY25.

    • Mahad ramp-up continued to be a drag on consolidated EBITDA margins by 1% to 1.5%.

    • Raw material costs (Gum turpentine, CST, alpha-pinene) are at all-time highs, and crude-based products remain firm.

    • Indian rupee depreciation substantially impacted import costs across all three divisions.

    • Q4 FY26 total production volume declined by 7% QoQ and 14% YoY.

    Key financials

    Metrics

    9

    Periods

    2

    Q4 FY26

    3
    • Operating Revenue
      ₹282 Cr
      YoY+11%QoQ+12%
    • EBITDA Margin
      6.9%
    • Profit After Tax
      ₹3.98 Cr

    FY26

    6
    • Operating Revenue
      ₹1,030.8 Cr
      YoY+11%
    • EBITDA
      ₹68 Cr
      YoY-27.1%
    • EBITDA Margin
      6.6%
    • Profit After Tax
      ₹3.3 Cr
      YoY-90.4%
    • Net Debt Equity Ratio
      0.58 x

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    0.6x EBITDA

    Dividend

    ₹0.5/share (final)

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Peak Revenue (excluding Mahad)
    INR 1200-1250 crores
    Medium
    Revenue
    Mahad Additional Revenue (current capacity)
    INR 50 crores
    High
    Revenue
    Mahad Revenue (optimum utilization)
    INR 60-65 crores
    High
    Revenue
    Mahad Revenue (conservative FY27)
    INR 50 crore
    High
    Capacity Utilization
    Mahad Plant Utilization
    75-80%
    High
    Profitability
    Mahad Plant EBITDA Contribution
    EBITDA neutral and start contributing
    High
    Profitability
    Consolidated EBITDA Margin
    around 10%
    Medium

    Mahad Plant Utilization

    next one year
    CurrentBelow 75%
    Target75-80%

    Why it matters

    Achieving target utilization is key for Mahad to become EBITDA neutral and contribute positively to overall margins.

    So, I mean, we are very confident that in the next one year, we should be in a position to achieve utilization of the plant which is anywhere between 75% to 80%.

    How to verify

    guidance_and_targets[metric='Mahad Plant Utilization']

    Risks & concerns

    7
    RiskSeverity

    Raw Material Price Volatility

    Gum turpentine, CST, and alpha-pinene prices are at all-time highs; crude oil and crude-based products remain firm.Management acknowledged

    high

    Currency Depreciation

    Indian rupee depreciation substantially impacted import costs across all three divisions.Management acknowledged

    high

    Mahad Plant Ramp-up Drag

    Mahad plant's ramp-up phase continued to be a drag on consolidated EBITDA margins by 1% to 1.5%.Management acknowledged

    medium

    China Overcapacity and Buyer's Market

    Global market remains a buyer's market due to Chinese capacity, leading to subdued end-product pricing in aroma ingredients.Management acknowledged

    high

    Indian Camphor Overcapacity

    Substantial domestic capacity additions for synthetic camphor have created an oversupply exceeding demand in India.Management acknowledged

    high

    Pricing Pressure and Customer Resistance

    Customers are resisting price increases in a buyer's market, requiring phased pass-through mechanisms.Management acknowledged

    high

    Demand Cyclicality/Discretionary Perception

    Consumer behavior is cautious, and fragrance/flavors are perceived as discretionary, impacting demand.Management acknowledged

    medium

    Q&A highlights

    8

    “We have already initiated a dialogue with the central government on this subject twice. We are discussing this subject at other levels as well. As soon as there is any development in this, we will update you.”

    Analyst raised a recurring concern about import impact, and management confirmed ongoing efforts with the government, indicating a potential future policy change.

    asked by Rajesh Mishra

    2 min read7 chapters

    Detailed Narrative

    01

    FY26 Performance Overview and Milestone Achievement

    Oriental Aromatics Limited achieved a significant milestone in FY26, with consolidated revenue from operations crossing the INR 1,000 crore mark for the first time, reaching INR 1,030 crores. This represents an 11% year-on-year growth compared to INR 928 crores in the previous year. Despite this top-line growth, the year was challenging, with EBITDA margins compressing to 6.60% from 10.06% in FY25, and PAT margins falling to 0.32% from 3.7% in FY25.

    02

    Q4 FY26 Operational Highlights and Volume Trends

    In Q4 FY26, the company reported an operating revenue of INR 282 crore, showing a healthy 12% quarter-on-quarter and 11% year-on-year growth. Total sales volume increased by 16% compared to Q3 FY26 and registered a 5% growth on a year-on-year basis. However, total production volume declined by 7% QoQ and 14% YoY, primarily due to product mix changes and trial runs in the Specialty Chemicals division.

    03

    Factors Impacting Profitability and Margin Compression

    The compression in EBITDA margins was attributed to a combination of factors: pricing pressure on the ingredient side, raw material cost inflation (Gum turpentine, CST, alpha-pinene at all-time highs), and substantial Indian rupee depreciation impacting import costs across all three divisions. Additionally, the Mahad plant's ramp-up phase continued to be a drag, impacting consolidated EBITDA margins by 1% to 1.5%.

    04

    Mahad Plant Update and Future Outlook

    The Mahad facility has shown positive product acceptance, with sampling cycles completed and commercial shipments commenced. Management expects the plant to achieve 75% to 80% utilization within the next year, at which point it should become EBITDA neutral and start contributing positively. The initial investment for the plant was around INR 60-65 crores, with an additional INR 20-27 crores for utility base, and capacity can be doubled with a further INR 12-15 crores CAPEX.

    05

    Camphor and Terpene Chemicals Division Dynamics

    The Camphor and Terpene Chemicals division operated at healthy utilization levels. While Q4 is seasonally softer, the Indian camphor market faces oversupply due to substantial domestic capacity additions. Management noted that overcapacity in India is a bigger challenge than natural camphor imports from China, and they are exploring opportunities to ensure growth in this segment.

    06

    Pricing Environment and Pass-Through Strategy

    The broader market remains a buyer's market globally, leading to subdued end-product pricing. Despite significant increases in input costs (25-27%), customer resistance has necessitated breaking price increases into incremental, three-month adjustments. For spot materials, a new price list is issued monthly to ensure immediate pass-through of cost changes.

    07

    Capital Allocation and Shareholder Returns

    The company maintains a comfortable leverage position with a net debt-equity ratio of 0.58x as of March 31, 2026. The Board recommended a final dividend of INR 0.50 per equity share for FY26, subject to shareholder approval. Management emphasized a consolidation mode, focusing on extracting maximum benefits from existing investments and preserving profit, while remaining open to expansion ideas.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.